Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials
- 1 July 1997
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (4) , 778-797
- https://doi.org/10.1016/s0149-2918(97)80102-6
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductaseThe American Journal of Cardiology, 1994
- Meta-analysis. A quantitative approach to research integrationJAMA, 1988
- Meta-Analysis in Clinical ResearchAnnals of Internal Medicine, 1987
- Cholesterol and mortality. 30 years of follow-up from the Framingham studyJAMA, 1987
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986
- Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA, 1986
- Estimation of effect size from a series of independent experiments.Psychological Bulletin, 1982
- Lipoproteins, cardiovascular disease, and death. The Framingham studyArchives of internal medicine (1960), 1981